Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Conditions
Leukemia
What is the purpose of this trial?
RATIONALE: Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.
PURPOSE: This research study is developing a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia.
Participation Guidelines
- Age:
- Up to 30 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Children's Oncology Group
National Cancer Institute (NCI) - Dates:
- August 2010
- Last Updated:
- October 27, 2011
- Study HIC#:
- 1008007227
Clinicaltrials.gov ID: NCT01142427
For more information about this trial, contact:
Investigator
Nina Kadan-Lottick, MD
Principal Investigator
